October 31, 2024

FDA clears second set of changes to iRhythm Zio AT to resolve warning letter

October 31, 2024

iRhythm Technologies (Nasdaq:IRTC) announced that the FDA granted 510(k) clearance for Zio AT design modifications and labeling updates.

October 31, 2024

SynCardia announced today that it received a second patent expanding the coverage of its fully implantable artificial heart technology.

October 31, 2024

Exactech announced today that it received FDA 510(k) clearance for its Truliant porous tibial tray, a 3D tibial knee implant.